Safety evaluation of immunomodulatory biopharmaceuticals: can we improve the predictive value of preclinical studies?
- Resource Type
- Article
- Authors
- Black, L.E.; Green, J.D.; Rener, J.; Dayan, A.; Cavagnaro, J.A.; Spindler, P.; Bussiere, J.L.; Bouchard, P.; Inoue, T.; Thomas, P.T.; Essayan, D.M.; Gillett, N.A.; Hart, T.K.; Hastings, K.; House, R.V.; Latta, D.; Liminga, U.; Treacy, G.; Wierda, D.
- Source
- Human & Experimental Toxicology. Apr2000, Vol. 19 Issue 4, p205-207. 3p.
- Subject
- *ACCIDENT prevention
*IMMUNOLOGICAL adjuvants
*IMMUNOLOGIC diseases
*CONFERENCES & conventions
- Language
- ISSN
- 0960-3271
Presents information about a conference on safety evaluation. Introduction of immunomodulators for diseases of the immune system; Discussion on ways to improve the predictive value of preclinical studies; Topics addressed by papers presented at the conference.